Prediagnostic serum organochlorine concentrations and metastatic prostate cancer: A nested case-control study in the Norwegian Janus Serum Bank Cohort

Environmental Health Perspectives

Volumn 123, Issue 9, 2015, Pages 867-872

  Koutros, Stella ^a   Langseth, Hilde ^b   Grimsrud, Tom K ^b   Barr, Dana Boyd ^c   Vermeulen, Roel ^d   Portengen, Lützen ^d   Wacholder, Sholom ^a   Beane Freeman, Laura E ^a   Blair, Aaron ^a   Hayes, Richard B ^e   Rothman, Nathaniel ^a   Engel, Lawrence S ^f  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CANCER REGISTRY OF NORWAY   (Norway)

^c EMORY UNIVERSITY   (United States)

^d UTRECHT UNIVERSITY   (Netherlands)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1, 1 DICHLORO 2, 2 BIS (4 CHLOROPHENYL) ETHYLENE; BETA HEXACHLOROCYCLOHEXANE; CHLORPHENOTANE; DIELDRIN; HEPTACHLOR EPOXIDE; HEXACHLOROBENZENE; LINDANE; MIREX; NONACHLOR; ORGANOCHLORINE DERIVATIVE; OXYCHLORDANE; POLYCHLORINATED BIPHENYL; POLYCHLORINATED BIPHENYL DERIVATIVE; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG; CHLORINATED HYDROCARBON; INSECTICIDE;

ADULT; ARTICLE; BODY MASS; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; METASTASIS; NORWAY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; SMOKING; AGED; BLOOD; CHEMICALLY INDUCED; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; STATISTICAL MODEL;

ADULT; AGED; CASE-CONTROL STUDIES; HUMANS; HYDROCARBONS, CHLORINATED; INSECTICIDES; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NORWAY; POLYCHLORINATED BIPHENYLS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS;

EID: 84940732404     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1408245     Document Type: Article

References (32)

1. Aronson KJ, Wilson JW, Hamel M, Diarsvitri W, Fan W, Woolcott C, et al. 2010. Plasma organochlorine levels and prostate cancer risk. J Expo Sci Environ Epidemiol 20:434-445.
2. Cancer Registry of Norway. 2014. Janus Serum Bank Homepage [in Norwegian]. Available: http://www.kreftregisteret.no/janus [accessed 15 January 2015].
3. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, et al. 2009. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 30:293-342
4. Engel LS, Laden F, Andersen A, Strickland PT, Blair A, Needham LL, et al. 2007. Polychlorinated biphenyl levels in peripheral blood and non-Hodgkin’s lymphoma: a report from three cohorts. Cancer Res 67:5545-5552.
5. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willect WC. 2007. Risk factors for prostate cancer incidence and progression in the health profes-sionals follow-up study. Int J Cancer 121:1571-1578.
6. Hardell L, Andersson SO, Carlberg M, Bohr L, van Bavel B, Lindström G, et al. 2006. Adipose tissue concentrations of persistent organic pollutants and the risk of prostate cancer. J Occup Environ Med 48:700-707.
7. IARC (International Agency for Research on Cancer). 1991. Insecticides. IARC Monogr Eval Carcinog Risk Hum 53:45-349.
8. IARC (International Agency for Research on Cancer). 2001. Chlordane and heptachlor. IARC Monogr Eval Carcinog Risk Hum 79:411-492.
9. IARC (International Agency for Research on Cancer). 2012. Chemical agents and related occupations. IARC Monogr Eval Carcinog Risk Hum 100F.
10. Koutros S, Beane Freeman LE, Lubin JH, Heltshe SL, Andreotti G, Barry KH, et al. 2013. Risk of total and aggressive prostate cancer and pesticide use in the Agricultural Health Study. Am J Epidemiol 177:59-74.
11. Kumar V, Yadav CS, Singh S, Goel S, Ahmed RS, Gupta S, et al. 2010. CYP 1A1 polymorphism and organochlorine pesticides levels in the etiology of prostate cancer. Chemosphere 81:464-468.
12. Kvåle R, Auvinen A, Adami HO, Klint A, Hernes E, Møller B, et al. 2007. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst 99:1881-1887.
13. Kvalem HE, Knutsen HK, Thomsen C, Haugen M, Stigum H, Brantsaeter AL, et al. 2009. Role of dietary patterns for dioxin and PCB exposure. Mol Nutr Food Res 53:1438-1451.
14. Langseth H, Luostarinen T, Bray F, Dillner J. 2010. Ensuring quality in studies linking cancer registries and biobanks. Acta Oncol 49:368-377.
15. Lauby-Secretan B, Loomis D, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, et al. 2013. Carcinogenicity of polychlorinated biphenyls and polybrominated biphenyls. Lancet Oncol 14:287-288.
16. Longnecker MP, Rogan WJ, Lucier G. 1997. The human health effects of DDT (dichlorodiphenyltrichloro-ethane) and PCBs (polychlorinated biphenyls) and an overview of organochlorines in public health. Annu Rev Public Health 18:211-244.
17. Lubin JH, Colt JS, Camann D, Davis S, Cerhan JR, Severson RK, et al. 2004. Epidemiologic evaluation of measurement data in the presence of detec-tion limits. Environ Health Perspect 112:1691-1696; doi:10.1289/ehp.7199.
18. McFarland VA, Clarke JU. 1989. Environmental occur-rence, abundance, and potential toxicity of poly-chlorinated biphenyl congeners: considerations for a congener-specific analysis. Environ Health Perspect 81:225-239.
19. Multigner L, Ndong JR, Giusti A, Romana M, Delacroix-Maillard H, Cordier S, et al. 2010. Chlordecone exposure and risk of prostate cancer. J Clin Oncol 28:3457-3462.
20. Pavuk M, Cerhan JR, Lynch CF, Schecter A, Petrik J, Chovancova J, et al. 2004. Environmental exposure to PCBs and cancer incidence in eastern Slovakia. Chemosphere 54:1509-1520.
21. Percy CL, Berg JW, Thomas LB, eds. 1968. Manual of Tumor Nomenclature and Coding. New York: American Cancer Society.
22. Prince MM, Ruder AM, Hein MJ, Waters MA, Whelan EA, Nilsen N, et al. 2006. Mortality and exposure response among 14,458 electrical capacitor manufacturing workers exposed to poly chlorinated biphenyls (PCBs). Environ Health Perspect 114:1508-1514; doi:10.1289/ehp.9175.
23. Purdue MP, Engel LS, Langseth H, Needham LL, Andersen A, Barr DB, et al. 2009. Prediagnostic serum concentrations of organochlorine compounds and risk of testicular germ cell tumors. Environ Health Perspect 117:1514-1519; doi:10.1289/ehp.0800359.
24. Purdue MP, Hoppin JA, Blair A, Dosemeci M, Alavanja MC. 2007. Occupational exposure to organochlorine insecticides and cancer incidence in the Agricultural Health Study. Int J Cancer 120:642-649.
25. Ritchie JM, Vial SL, Fuortes LJ, Guo H, Reedy VE, Smith EM. 2003. Organochlorines and risk of prostate cancer. J Occup Environ Med 45:692-702.
26. Ritchie JM, Vial SL, Fuortes LJ, Robertson LW, Guo H, Reedy VE, et al. 2005. Comparison of proposed frameworks for grouping polychlorinated biphenyl congener data applied to a case-control pilot study of prostate cancer. Environ Res 98:104-113.
27. Sawada N, Iwasaki M, Inoue M, Itoh H, Sasazuki S, Yamaji T, et al. 2010. Plasma organochlorines and subsequent risk of prostate cancer in Japanese men: a nested case-control study. Environ Health Perspect 118:659-665; doi:10.1289/ehp.0901214.
28. Schecter A, Colacino J, Haffner D, Patel K, Opel M, Päpke O, et al. 2010. Perfluorinated compounds, polychlorinated biphenyls, and organochlorine pesticide contamination in composite food samples from Dallas, Texas, USA. Environ Health Perspect 118:796-802; doi:10.1289/ehp.0901347.
29. Van Maele-Fabry G, Willems JL. 2004. Prostate cancer among pesticide applicators: a meta-analysis. Int Arch Occup Environ Health 77:559-570.
30. Wolff MS, Camann D, Gammon M, Stellman SD. 1997. Proposed PCB congener groupings for epidemiological studies [Letter]. Environ Health Perspect 105:13-14.
31. World Health Organization. 1976. International Classification of Diseases for Oncology (ICD-O). Geneva: World Health Organization.
32. Xu X, Dailey AB, Talbott EO, Ilacqua VA, Kearney G, Asal NR. 2010. Associations of serum concentrations of organochlorine pesticides with breast cancer and prostate cancer in U.S. adults. Environ Health Perspect 118:60-66; doi:10.1289/ehp.0900919.